257
Views
4
CrossRef citations to date
0
Altmetric
Review

Druggable molecular alterations in bile duct cancer: potential and current therapeutic applications in clinical trials

, , , , & ORCID Icon
Pages 975-983 | Received 10 Mar 2021, Accepted 02 Aug 2021, Published online: 22 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gaya Spolverato, Dajana Glavas, D. Brock Hewitt, Zachary J Brown, Giulia Capelli, Francesca Bergamo, Mario Domenico Rizzato & Timothy M. Pawlik. (2022) Advances in pharmacotherapy for cholangiocarcinoma: from conventional therapies to targeted drugs. Expert Opinion on Pharmacotherapy 23:4, pages 473-481.
Read now

Articles from other publishers (3)

Julien Edeline & Angela Lamarca. (2023) Practicalities accessing precision medicine in biliary tract cancer. The Lancet Gastroenterology & Hepatology 8:1, pages 5-6.
Crossref
Eileen M. O'Reilly & Andrew H. Ko. (2022) Precision Medicine and Immunotherapy in GI Cancers. Journal of Clinical Oncology 40:24, pages 2659-2661.
Crossref
May T. Cho, Sepideh Gholami, Dorina Gui, Sooraj L. Tejaswi, Ghaneh Fananapazir, Nadine Abi-Jaoudeh, Zeljka Jutric, Jason B. Samarasena, Xiaodong Li, Jennifer B. Valerin, Jacob Mercer & Farshid Dayyani. (2022) Optimizing the Diagnosis and Biomarker Testing for Patients with Intrahepatic Cholangiocarcinoma: A Multidisciplinary Approach. Cancers 14:2, pages 392.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.